a Smptomatic Bacteriuria in Pregnancy
a Symptomatic Bacteriuria in Pregnant Females
1 other identifier
observational
320
1 country
1
Brief Summary
Asymptomatic bacteriuria (ASB) is defined as the presence of at least 105 colony-forming units (CFU)/ml of 1 or 2 bacterial species in clean-voided midstream urine sample from an individual without symptoms of UTI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2018
CompletedFirst Posted
Study publicly available on registry
April 17, 2018
CompletedStudy Start
First participant enrolled
April 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2019
CompletedJanuary 9, 2019
January 1, 2019
1 year
April 6, 2018
January 8, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The number of participants who will discovered to have bacteriuria
Incidence of asymptomatic bacteriuria among pregnant females.
within 4 weeks
Study Arms (3)
pregnant women in first Trimester
A urine sample will be taken from pregnant women before 14 weeks of pregnancy
pregnant women in second Trimester
A urine sample will be taken from pregnant women from 14 weeks +1 day till 28 weeks
pregnant women in third Trimester
A urine sample will be taken from pregnant women from 28 weeks +1 day till 40 weeks
Interventions
Intervention is (urine analysis ): of a mid stream urine sample will be taken
Eligibility Criteria
Pregnant non-symptomatic females.
You may qualify if:
- \. Pregnant females 2. Non-symptomatic females.
You may not qualify if:
- \. Patients taking antibiotics in the last two weeks. 2. Symptomatic UTI. 3. Suspected urinary tract abnormalities. 4. Urinary catheterization. 5. Renal dialysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aljazeera Hospitallead
- Kasr El Aini Hospitalcollaborator
Study Sites (1)
Algazeerah
Giza, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud Alalfy
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital
Study Record Dates
First Submitted
April 6, 2018
First Posted
April 17, 2018
Study Start
April 17, 2018
Primary Completion
May 1, 2019
Study Completion
July 15, 2019
Last Updated
January 9, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share
The research will be published after finishing results